Log in to save to my catalogue

In Vivo Selection Yields AAV-B1 Capsid for Central Nervous System and Muscle Gene Therapy

In Vivo Selection Yields AAV-B1 Capsid for Central Nervous System and Muscle Gene Therapy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5088762

In Vivo Selection Yields AAV-B1 Capsid for Central Nervous System and Muscle Gene Therapy

About this item

Full title

In Vivo Selection Yields AAV-B1 Capsid for Central Nervous System and Muscle Gene Therapy

Publisher

United States: Elsevier Inc

Journal title

Molecular therapy, 2016-08, Vol.24 (7), p.1247-1257

Language

English

Formats

Publication information

Publisher

United States: Elsevier Inc

More information

Scope and Contents

Contents

Adeno-associated viral (AAV) vectors have shown promise as a platform for gene therapy of neurological disorders. Achieving global gene delivery to the central nervous system (CNS) is key for development of effective therapies for many of these diseases. Here we report the isolation of a novel CNS tropic AAV capsid, AAV-B1, after a single round of...

Alternative Titles

Full title

In Vivo Selection Yields AAV-B1 Capsid for Central Nervous System and Muscle Gene Therapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5088762

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5088762

Other Identifiers

ISSN

1525-0016

E-ISSN

1525-0024

DOI

10.1038/mt.2016.84

How to access this item